Former Chief Executive Officer · BIOGEN INC. (BIIB)

Michel Vounatsos

A named executive officer of BIOGEN in every fiscal year CompBrief holds from FY2016 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$26,625,221

Salary $1,626,039Stock awards $15,389,732

FY2021: $17,689,665

2nd of 7 named executive officers at Biogen by FY2022 total.

7 named officers on file for BIOGEN, FY2022

Michel Vounatsos’s pay file — $29

  • 7 fiscal years of pay, line by line
  • 11 equity grants, each cited to its filing
  • BIIB’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BIOGEN’s whole pay program stands against its peers

  • BIOGEN’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BIIB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2023 (DEF 14A).

Free

Get Michel Vounatsos’s full pay file as a PDF — free

More than this page: up to 10 years of Michel’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Michel Vounatsos compensation by year

BIOGEN Summary Compensation Table · all 7 fiscal years held
In US dollars, as BIOGEN reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020FY2021FY2022
Salary$519,231$1,087,885$1,276,923$1,388,461$1,488,462$1,533,173$1,626,039
Bonus$1,500,000$0$0$0$0$0$0
Stock awards$3,151,199$9,868,540$11,064,897$12,352,030$13,887,064$14,084,314$15,389,732
Option awards$0$0$0$0$0$0$0
Non-equity incentive$447,799$2,502,500$3,337,880$3,884,000$2,565,000$1,153,125$0
Pension and deferred compensation$1,598$18,881$80,663$85,667$264,358$494,290$541,661
All other$181,568$186,567$408,283$449,700$454,945$424,763$9,067,789
Total$5,801,395$13,664,373$16,168,646$18,159,858$18,659,829$17,689,665$26,625,221

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOGEN INC. DEF 14A filed April 28, 2023, accession 0001193125-23-127639, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BIOGEN INC. filed document, accession 0001193125-23-127639. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2023.

$5.8M
$13.7M
$16.2M
$18.2M
$18.7M
$17.7M
$26.6M
FY16
FY17
FY18
FY19
FY20
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU28,878$7,996,896—
PSU11,170$3,093,196—
RSU7,211$1,996,870—
PSU4,750$1,315,370—

Per the Outstanding Equity Awards at Fiscal Year-End table in BIOGEN INC.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

BIOGEN’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Christopher ViehbacherPresident and Chief Executive Officer$30,488,593
Michel Vounatsos · this pageFormer Chief Executive Officer$26,625,221
Michael McDonnellExecutive Vice President and Chief Financial Officer$7,209,834
Susan AlexanderExecutive Vice President, Chief Legal Officer and Secretary$6,790,152
Chirfi GuindoFormer Executive Vice President, Global Product Strategy and Commercialization$5,382,348
Ginger GregoryExecutive Vice President, Chief Human Resources Officer$5,080,258
Nicole MurphyExecutive Vice President, Head of Pharmaceutical Operations and Technology$4,929,712

Board service

BIOGEN board · FY2021

How this board is paid

Company policy: BIOGEN pays directors a $125,000 cash retainer and $270,000 in RSUs. As stated in BIOGEN's FY2021 proxy.

The full BIOGEN compensation record

free company brief

This page is one person within BIOGEN's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BIOGEN proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIOGEN's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michel Vounatsos's compensation dossier · One-time report. No refunds.